Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04931511Phase 4Terminated
Phase 4, randomised, double-blind trial of betamethasone in adhesive capsulitis (AC), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Shoulder Pain and Disability Index at 12 weeks. Started Jun 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04931511.